Lupin Ltd. (LUPIN): Lupin Share Price rises 2.04% to Rs 2,089.05; market cap at Rs 93,984.14 crore

Published: 17 September 2026 at 3:18:42 PM IST

Lupin Share Price rose today as the stock advanced 2.04% to Rs 2,089.05 from the previous close of Rs 2,047.20, taking the company’s market capitalisation to Rs 93,984.14 crore. The move keeps Lupin in focus across Lupin Share Price Today, Lupin Stock News and broader share price rise searches on the Indian Stock Market. The data confirms a same-day price event, while a company-specific catalyst is not established in the supplied numbers. For readers tracking Lupin Share Price Live, the key verified context is simple: the stock opened at Rs 2,048.15, moved between Rs 2,047.45 and Rs 2,090.75, and recorded turnover of Rs 2.56 crore. Univest is highlighting the day’s price action, valuation, sector benchmark and peer positioning so investors can interpret the move with facts rather than assumption.

Lupin Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,089.05
Previous Close	Rs 2,047.2
Today's Move	Rs 41.85 (+2.04%)
Open	Rs 2,048.15
High	Rs 2,090.75
Low	Rs 2,047.45
Turnover	Rs 2.56 crore
Market Capitalisation	Rs 93,984.14 crore
Market Cap Category	Large Cap

Lupin Ltd. (LUPIN) rose to Rs 2,089.05 from the previous close of Rs 2,047.2, a move of Rs 41.85 or 2.04%. The stock opened at Rs 2,048.15, reached a high of Rs 2,090.75, recorded a low of Rs 2,047.45.

Lupin Share Price Today reflects a clear same-day gain of Rs 41.85, or 2.04%, with the stock ending at Rs 2,089.05 versus the previous close of Rs 2,047.20. The day opened at Rs 2,048.15, traded within a range of Rs 2,047.45 to Rs 2,090.75, and finished close to the session high. Turnover stood at Rs 2.56 crore, which is a factual traded-value metric and not a signal by itself. On this Lupin Share Price Update, the verified numbers show a firm move in the stock price, but the supplied data does not establish a company-specific trigger. That is why Univest treats this as an event-led price rise rather than a catalyst-led story.

Lupin Ltd. (LUPIN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 93,984.14 crore
P/E Ratio	16.93x
P/B Ratio	3.93x
ROE	27.11%
ROCE	28.86%
EPS	Rs 120.91
Book Value Per Share	Rs 520.51
Dividend Yield	0.88%

Lupin Ltd. (LUPIN) fundamental metrics show P/E 16.93x, P/B 3.93x, ROE 27.11%, ROCE 28.86%. These figures provide context only and are not a buy or sell signal.

Lupin Ltd. has a market capitalisation of Rs 93984.14 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.93x, P/B at 3.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.11% and ROCE of 28.86%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 120.91, book value per share of Rs 520.51, dividend yield of 0.88%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	16.93x
Benchmark Median P/E	31.35x
Benchmark Average P/E	47.81x
Benchmark P/E Range	3.45x to 661.74x
Company P/B Ratio	3.93x
Benchmark Median P/B	2.98x
Company ROE	27.11%
Benchmark Median ROE	11.78%
Company ROCE	28.86%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 93,984.14 crore
Benchmark Median Market Cap	Rs 735.67 crore

Lupin Ltd. (LUPIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Lupin Ltd. (LUPIN) has a P/E ratio of 16.93x, which is below the benchmark median of 31.35x, a difference of -46%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Lupin Ltd. (LUPIN) has a ROE of 27.11%, which is above the benchmark median of 11.78%, a difference of +130.14%. Lupin Ltd. (LUPIN) has a ROCE of 28.86%, which is above the benchmark median of 13.65%, a difference of +111.43%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,277.97	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,43,965.63	83.5	13.83	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.11	20.44	26.76	19.27
Cipla Ltd.	CIPLA	1,09,949.53	32.59	3.12	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,625.67	24.42	4.09	19.69	21.39

Lupin Ltd. (LUPIN) has a P/E ratio of 16.93x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.11% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 28.86% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Lupin Ltd. (LUPIN) has a market capitalisation of Rs 93,984.14 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Lupin

• Lupin Share Price rose 2.04% today to Rs 2,089.05 after closing at Rs 2,047.20 previously.
• The stock moved between Rs 2,047.45 and Rs 2,090.75 during the session and finished near the day’s high.
• Market capitalisation stood at Rs 93,984.14 crore, keeping Lupin among the larger Healthcare names.
• P/E of 16.93, ROE of 27.11% and ROCE of 28.86% provide a clear fundamental reference point.
• Peer comparison shows Lupin trading below several pharma names on P/E while holding stronger return ratios than many of them.

About Lupin

Lupin Ltd. is a Pharmaceuticals & Drugs company in the Healthcare sector. The business operates in a segment that is typically assessed through earnings, valuation ratios, returns on capital and peer comparison, all of which are available in today’s verified data. For Lupin Share Price readers, the relevant company profile is not a broad corporate description but the market-facing identity of a pharmaceutical manufacturer with a large market capitalisation, strong return ratios and visible presence in the listed healthcare universe.

In financial terms, Lupin’s profile is anchored by EPS of Rs 120.91, book value of Rs 520.51, dividend yield of 0.88%, ROE of 27.11% and ROCE of 28.86%. Those numbers help explain why Lupin Share Price Today is often tracked alongside Lupin Stock News and Lupin Fundamental Analysis. The company’s share price movement can be interpreted only against the verified financial context, sector comparison and market capitalisation rather than any unverified narrative. Univest keeps this overview concise so readers can connect Lupin Share Price with the company’s underlying financial profile.

Track Lupin Share Price on Univest

Use Lupin Ltd. (LUPIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets readers track Lupin Share Price Live with current price updates, price rise context, fundamental ratios, sector comparison, peer performance and broader market insights. Users can also review the shareholding pattern, 52-week levels and company news in one place. For anyone following Lupin Share Price Today, Univest brings the key facts together without adding speculation.

Frequently Asked Questions

Why did Lupin Share Price rise today?

Ans. Lupin Share Price rose 2.04% to Rs 2,089.05 in today’s trade. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. The previous close was Rs 2,047.2.

What is Lupin Share Price Today?

Ans. Lupin Share Price Today is Rs 2,089.05. The stock added Rs 41.85 from the previous close of Rs 2,047.20 and traded between Rs 2,047.45 and Rs 2,090.75 during the session.

What is Lupin’s market capitalisation?

Ans. Lupin’s market capitalisation stands at Rs 93,984.14 crore. That places the company well above the same-industry median market value shown in the benchmark snapshot for Pharmaceuticals & Drugs. The company operates in the Healthcare sector.

How does Lupin compare on valuation?

Ans. Lupin’s P/E ratio is 16.93 and its P/B ratio is 3.93. Compared with the sector benchmark, P/E is below the median and average, while P/B is above the median but below the average.

What do Lupin’s ROE and ROCE show?

Ans. Lupin reports ROE of 27.11% and ROCE of 28.86%. Both are above the same-industry benchmark medians, which provides useful financial context alongside the day’s Lupin Share Price move. ROE stands at 27.11%.

How does Lupin compare with peers?

Ans. In the supplied peer set, Lupin’s P/E is lower than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Zydus Lifesciences. Its ROE and ROCE also compare favourably with several of those listed peers.

Should investors track Lupin Share Price closely?

Ans. Lupin Share Price is worth tracking because the stock combines a same-day gain, a large market capitalisation, strong return ratios and a valuation that sits below several pharma peers on earnings multiples.

What should readers monitor next on Lupin?

Ans. Readers can monitor Lupin Share Price Live, the next company update, sector movement in Healthcare and any fresh financial disclosures. Univest tracks the same verified facts in one place for easier follow-up.